HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cautious notification and continual monitoring of patients with mild cognitive impairment.

Abstract
Mild cognitive impairment (MCI) is defined as 'a condition between a normal state and dementia indicated by a cognitive decline in comparison to previous results'. MCI groups as a whole are not necessarily in the prodromal stage of dementia. However, when patients are notified of their condition, communication must be cautious and account for the patient's personality, mental status, and examination findings. Hurriedly notifying patients may give the incorrect impression that they will certainly have dementia in the future and cause worry or emotional tension. The efficacy of pharmacotherapy and non-pharmacotherapy, such as cognitive function training, in preventing dementia in MCI patients has not yet been confirmed. As no particular types of intervention are currently shown to be effective for MCI, it is believed that periodically monitoring patients and providing lifestyle guidance, while also treating lifestyle-related diseases, is an appropriate treatment strategy for those with MCI.
AuthorsToshinari Odawara
JournalPsychogeriatrics : the official journal of the Japanese Psychogeriatric Society (Psychogeriatrics) Vol. 12 Issue 2 Pg. 131-2 (Jun 2012) ISSN: 1479-8301 [Electronic] England
PMID22712649 (Publication Type: Journal Article)
Copyright© 2012 The Author. Psychogeriatrics © 2012 Japanese Psychogeriatric Society.
Chemical References
  • Cholinesterase Inhibitors
  • Indans
  • Nootropic Agents
  • Piperidines
  • Donepezil
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (prevention & control)
  • Cholinesterase Inhibitors (therapeutic use)
  • Cognitive Dysfunction (psychology, therapy)
  • Combined Modality Therapy
  • Donepezil
  • Health Behavior
  • Humans
  • Indans (therapeutic use)
  • Japan
  • Life Style
  • Middle Aged
  • Nootropic Agents (therapeutic use)
  • Patient Education as Topic
  • Physician-Patient Relations
  • Piperidines (therapeutic use)
  • Treatment Outcome
  • Truth Disclosure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: